Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 23/08/2011
PIL Singulair Paediatric 5 mg Chewable Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/07/2010 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/09/2009 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/03/2009 and displayed until 09/09/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/08/2008 and displayed until 23/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/05/2008 and displayed until 11/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/12/2007 and displayed until 27/05/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   montelukast sodium